Keyphrases
Gadolinium
100%
Gadolinium-based Contrast
100%
Contrast Exposure
100%
Nephrogenic Systemic Fibrosis
100%
Gadolinium-based Contrast Agents
29%
Gadodiamide
16%
Dialysis Facility
16%
Dermatopathology
12%
Renal Failure
8%
Control Subjects
8%
Symptom Onset
8%
Renal Insufficiency
8%
Skin Samples
8%
Serum Antibody
4%
Acidosis
4%
Contrast Agent
4%
Risk Factors
4%
Angiotensin-converting Enzyme Inhibitor (ACEi)
4%
Renal Disease
4%
Dose-ranging
4%
Inflammatory Conditions
4%
Healthy Controls
4%
Biopsy Specimen
4%
Clinic Population
4%
Odds Ratio
4%
Retrospective Review
4%
Low Serum
4%
Hemoglobin Level
4%
Retrospective Chart Review
4%
Dialysis
4%
Skin Biopsy
4%
Tertiary Care Hospital
4%
Chronic Kidney Disease
4%
Low Hemoglobin
4%
Dermatology Clinic
4%
Erythropoietin
4%
Hemodialysis
4%
Likelihood Ratio
4%
Randomized Control
4%
Serum Calcium
4%
Control Specimen
4%
Energy Dispersive X-ray Spectroscopy
4%
Contrast Dose
4%
Gadopentetate
4%
Renal Dialysis
4%
Outpatient Dialysis
4%
Contrast-enhanced MR
4%
Contrast Agent Dose
4%
Immunology and Microbiology
Contrast Medium
100%
Prevalence
25%
Hemodialysis
25%
Antibody Blood Level
12%
Energy-Dispersive X-Ray Spectroscopy
12%
Hemoglobin Blood Level
12%
Magnetic Resonance Imaging
12%
Calcium Blood Level
12%
Erythropoietin
12%
Neuroscience
Contrast Medium
100%
Gadodiamide
50%
ACE Inhibitor
12%
Erythropoietin
12%
Magnetic Resonance Imaging
12%
Medicine and Dentistry
Energy Dispersive X-Ray Spectroscopy
4%